NCT05386056 2022-11-28Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell CarcinomaPeking UniversityPhase 2 Unknown54 enrolled
NCT05541445 2022-09-15Pembrolizumab Plus CRT Followed by Surgery in Upper ESCCCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 1/2 Unknown40 enrolled